Corrigendum To: Abstract 369, “cardiovascular Outcomes in Patients Treated with Ibrutinib and Related Therapies” [heart, Lung and Circulation, Volume 33, Supplement 4, August 2024, Pages S296–S297, (abstracts for the 72nd Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand, 1–4 August 2024, Perth, Australia)].